The neurodiagnostic and monitoring devices market share in the US is expected to increase by USD 595.30 million from 2020 to 2025, and the market's growth momentum will decelerate at a CAGR of 5.35%.

This neurodiagnostic and monitoring devices market research report of US provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers neurodiagnostic and monitoring devices market segmentation in the US by product (ICP monitoring devices, EEG devices, EMG devices, and others) and end-user (hospitals, clinics, and laboratories). The neurodiagnostic and monitoring devices market report of US also offers information on several market vendors, including Advanced Brain Monitoring Inc., Cadwell Industries Inc., Compumedics Ltd., General Electric Co., Koninklijke Philips NV, Masimo Corp., Medtronic Plc, Natus Medical Inc., Nihon Kohden Corp., and Viasonix Ltd among others.

What will the Neurodiagnostic and Monitoring Devices Market Size in US be During the Forecast Period?

Download the Free Report Sample to Unlock the Neurodiagnostic and Monitoring Devices Market Size in US for the Forecast Period and Other Important Statistics

Neurodiagnostic and Monitoring Devices Market in US: Key Drivers and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The increasing incidences and prevalence of neurological conditions are notably driving the neurodiagnostic and monitoring devices market growth in the US, although factors such as high costs associated with neurodiagnostic and monitoring devices may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the neurodiagnostic and monitoring devices industry in the US. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Neurodiagnostic and Monitoring Devices Market Driver in US

One of the key factors driving growth in the neurodiagnostic and monitoring devices market in the US is the increasing incidences and prevalence of neurological conditions. Patients with a comprehensive range of neurological disorders, including epilepsy, stroke, Parkinson's disease, and brain tumors, have a high risk of developing a disability. These neurological disorders develop due to various factors such as bacterial and viral infections, genetic factors, and the lack of immune response. Healthcare professionals use neurodiagnostic and monitoring devices such as EEG, EMG, MEG, and ICP to diagnose neurological diseases for further interventions to save the life of the patients. Factors such as the increasing incidence and prevalence of various neurological diseases and the growing demand for treating diseases to save the lives of the patients will contribute to the growth of the neurodiagnostic and monitoring devices market in the US. Furthermore, the treatment of brain hemorrhage, which can occur due to stroke and brain tumors, is boosting the demand for neurodiagnostic and monitoring devices market in the US.

Key Neurodiagnostic and Monitoring Devices Market Challenge in US

The costs of neurodiagnostic procedures and devices are very high. The total cost of a neurodiagnostic procedure depends on the cost of the devices, cost of the procedure, and fees of the healthcare professionals performing the procedure. The shelf life of the devices depends on the maintenance of the devices. The need for the maintenance of neurodiagnostic devices and their accessories creates a burden on the end-user facilities and hinders their adoption. The high cost of intracranial pressure monitoring systems and surgical procedures has adversely impacted the adoption of intracranial pressure monitoring systems. Therefore, the high cost of neurodiagnostic devices and procedures may hamper the growth of the neurodiagnostic and monitoring devices market in the US during the forecast period.

This neurodiagnostic and monitoring devices market in the US analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Neurodiagnostic and Monitoring Devices Market Vendors in US?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Advanced Brain Monitoring Inc.
• Cadwell Industries Inc.
• Compumedics Ltd.
• General Electric Co.
• Koninklijke Philips NV
• Masimo Corp.
• Medtronic Plc
• Natus Medical Inc.
• Nihon Kohden Corp.
• Viasonix Ltd

This statistical study of the neurodiagnostic and monitoring devices market in US encompasses successful business strategies deployed by the key vendors. The neurodiagnostic and monitoring devices market in US is fragmented and the vendors are deploying growth strategies such as focusing on mergers and acquisitions to enhance their product portfolios to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The neurodiagnostic and monitoring devices market forecast report of US offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

What are the Revenue-generating Product Segments in the Neurodiagnostic and Monitoring Devices Market in US?

To gain further insights on the market contribution of various segments Request for a FREE sample

The neurodiagnostic and monitoring devices market share growth in the US by the ICP monitoring devices segment will be significant during the forecast period. Factors such as the growing number of traumatic brain injury (TBI) and brain tumor cases, the rising number of product launches, and the increasing presence of vendors are boosting the adoption of ICP devices in the market.

This report provides an accurate prediction of the contribution of all the segments to the growth of the neurodiagnostic and monitoring devices market size in US and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Neurodiagnostic and Monitoring Devices Market Report of US?

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive neurodiagnostic and monitoring devices market growth in US during the next five years
• Precise estimation of the neurodiagnostic and monitoring devices market size in US and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of neurodiagnostic and monitoring devices market vendors in US 

We can help! Our analysts can customize this report to meet your requirements. Get in touch